liver function tests

Summary

Top Publications

  1. ncbi The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients
    Sherene Shalhub
    Department of Surgery and Interdisciplinary Obesity Study Group, University of South Florida Health Sciences Center, Tampa, FL 33601, USA
    Obes Surg 14:54-9. 2004
  2. ncbi Liver enzyme alteration: a guide for clinicians
    Edoardo G Giannini
    Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy
    CMAJ 172:367-79. 2005
  3. ncbi Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town
    Gaspare Maria Pendino
    Divisione di Medicina 1, Policlinico Madonna della Consolazione, Reggio Calabria, Italy
    Hepatology 41:1151-9. 2005
  4. ncbi Postoperative changes in liver function tests: randomized comparison of low- and high-pressure laparoscopic cholecystectomy
    S Hasukic
    Department of Surgery, University Clinical Center Tuzla, Faculty of Medicine, University of Tuzla, Trnovac b b, 75, 000, Tuzla, Bosnia Herzegovina
    Surg Endosc 19:1451-5. 2005
  5. ncbi Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters
    Anna Maria Wolf
    Department of Visceral and Transplantation Surgery, University Hospital Ulm, Germany
    Obes Surg 15:228-37. 2005
  6. ncbi Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study
    Philippe Halfon
    Department of Virology, Alphabio Laboratory, 23 Street of Friedland, 13006 Marseille, France
    Am J Gastroenterol 101:547-55. 2006
  7. ncbi Evaluation of liver fibrosis: a concise review
    Nezam H Afdhal
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02125, USA
    Am J Gastroenterol 99:1160-74. 2004
  8. ncbi Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
    E Martinez
    Unit of Infectious Diseases, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic Universitari, Barcelona, Spain
    AIDS 15:1261-8. 2001
  9. ncbi Non-alcoholic steatohepatitis in type 2 diabetes mellitus
    Parijat Gupte
    Gastroenterology Center, Jagjivanram Hospital, Mumbai Central, Mumbai, Maharashtra, India
    J Gastroenterol Hepatol 19:854-8. 2004
  10. ncbi Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide-induced hepatotoxicity
    T C Jeong
    Toxicology Research Center, Korea Research Institute of Chemical Technology, Taejon, South Korea
    Toxicol Lett 105:39-46. 1999

Research Grants

Detail Information

Publications245 found, 100 shown here

  1. ncbi The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients
    Sherene Shalhub
    Department of Surgery and Interdisciplinary Obesity Study Group, University of South Florida Health Sciences Center, Tampa, FL 33601, USA
    Obes Surg 14:54-9. 2004
    ....
  2. ncbi Liver enzyme alteration: a guide for clinicians
    Edoardo G Giannini
    Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy
    CMAJ 172:367-79. 2005
    ....
  3. ncbi Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town
    Gaspare Maria Pendino
    Divisione di Medicina 1, Policlinico Madonna della Consolazione, Reggio Calabria, Italy
    Hepatology 41:1151-9. 2005
    ....
  4. ncbi Postoperative changes in liver function tests: randomized comparison of low- and high-pressure laparoscopic cholecystectomy
    S Hasukic
    Department of Surgery, University Clinical Center Tuzla, Faculty of Medicine, University of Tuzla, Trnovac b b, 75, 000, Tuzla, Bosnia Herzegovina
    Surg Endosc 19:1451-5. 2005
    ..This study evaluated the changes in liver function tests after high-pressure LC (HPLC; 14 mmHg) and low-pressure LC (LPLC; 7 mmHg).
  5. ncbi Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters
    Anna Maria Wolf
    Department of Visceral and Transplantation Surgery, University Hospital Ulm, Germany
    Obes Surg 15:228-37. 2005
    ....
  6. ncbi Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study
    Philippe Halfon
    Department of Virology, Alphabio Laboratory, 23 Street of Friedland, 13006 Marseille, France
    Am J Gastroenterol 101:547-55. 2006
    ..CONCLUSIONS: This prospective independent and multicenter study confirms the diagnostic value of FT and AT found in the princeps study and suggests that FT and AT can be an alternative to biopsy in most patients with chronic HCV...
  7. ncbi Evaluation of liver fibrosis: a concise review
    Nezam H Afdhal
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02125, USA
    Am J Gastroenterol 99:1160-74. 2004
    ..The limitations of utilization of these markers for both cross-sectional diagnosis of fibrosis and monitoring disease progression or regression are discussed...
  8. ncbi Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
    E Martinez
    Unit of Infectious Diseases, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic Universitari, Barcelona, Spain
    AIDS 15:1261-8. 2001
    ..To assess the incidence and risk factors for hepatotoxicity associated with nevirapine...
  9. ncbi Non-alcoholic steatohepatitis in type 2 diabetes mellitus
    Parijat Gupte
    Gastroenterology Center, Jagjivanram Hospital, Mumbai Central, Mumbai, Maharashtra, India
    J Gastroenterol Hepatol 19:854-8. 2004
    ..CONCLUSION: We conclude that the prevalence of NASH is high in type 2 DM patients and liver biopsy is the only investigation to differentiate between non-alcoholic fatty liver and steatohepatitis...
  10. ncbi Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide-induced hepatotoxicity
    T C Jeong
    Toxicology Research Center, Korea Research Institute of Chemical Technology, Taejon, South Korea
    Toxicol Lett 105:39-46. 1999
    ..our present results suggest that beta-ionone may be a useful model inducer of P450 enzyme(s) in studying toxic mechanism of certain chemicals which require metabolic activation by P450s in mice...
  11. ncbi AGA technical review on the evaluation of liver chemistry tests
    Richard M Green
    Division of Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Gastroenterology 123:1367-84. 2002
  12. ncbi Autoimmune hepatitis
    Edward L Krawitt
    Department of Medicine, University of Vermont, Burlington, VT 05405-0068, USA
    N Engl J Med 354:54-66. 2006
  13. ncbi Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities
    Michael D McGoon
    Mayo Clinic, Rochester, MN 55905, USA
    Chest 135:122-9. 2009
    ..Because ambrisentan may provide benefits in PAH patients who have discontinued ERA therapy due to LFT abnormalities, we evaluated the safety and efficacy of ambrisentan in this patient population...
  14. ncbi Brief communication: clinical implications of short-term variability in liver function test results
    Mariana Lazo
    Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205 2223, USA
    Ann Intern Med 148:348-52. 2008
    ..Clinicians sometimes order liver tests as part of a screening examination or general work-up. Current guidelines do not recommend routine retesting of abnormal results in asymptomatic patients...
  15. ncbi Liver enzyme alterations after laparoscopic cholecystectomy
    H Erhan Guven
    3rd General Surgery Department, Ankara Oncology Research and Training Hospital, Demetevler Ankara, Turkey, 91 6 06500 Y Bahçelievler, Ankara, Turkey
    J Gastrointestin Liver Dis 16:391-4. 2007
    ....
  16. ncbi [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]
    Sonia Chavarría-Arciniega
    Clínica de Obesidad del Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
    Rev Invest Clin 57:505-12. 2005
    ..Hepatic biochemical test are abnormal. Despite the lack of its own morphological characteristics, NASH can be differentiated from other pathologies, the gold standard for diagnosis is liver biopsy...
  17. ncbi A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
    Guilherme M Campos
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143 0790, USA
    Hepatology 47:1916-23. 2008
    ....
  18. ncbi Liver damage in obese patients
    Antonio Del Gaudio
    Department of Surgery, University of Bologna, S Orsola Hospital, Via Massarenti, 9, I 40138 Bologna, Italy
    Obes Surg 12:802-4. 2002
    ..The aim of this study is to determine the hepatic conditions of morbidly obese patients during bariatric surgery by means of a wedge liver biopsy, to avoid any eventual hepatic damage being ascribed to the surgical procedure...
  19. ncbi Transient liver dysfunction after laparoscopic gastrectomy for gastric cancer patients
    Tsuyoshi Etoh
    Department of Surgery I, Oita University Faculty of Medicine, 1 1 Hasama machi, Oita, 879 5593, Japan
    World J Surg 31:1115-20. 2007
    ..The aim of this study was to clarify whether laparoscopy-assisted distal gastrectomy (LADG) is associated with changes in liver function compared with open distal gastrectomy (ODG)...
  20. ncbi Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI
    Henrik Nilsson
    Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden
    HPB (Oxford) 12:567-76. 2010
    ..The aim of this study was to determine whether the hepatic uptake and excretion of Gd-EOB-DTPA differ between patients with primary biliary cirrhosis (PBC) and healthy controls, and whether differences could be quantified...
  21. ncbi [Clinical characteristics of factory workers with asymptomatic liver function test abnormalities found on serial health examination]
    Kang Mo Kim
    Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
    Korean J Hepatol 11:144-56. 2005
    BACKGROUND/AIMS: The liver function tests (LFTs), such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltranspeptidase (gamma-GT), have been widely used as screening tests but their low positive ..
  22. ncbi Assessment of hepatic reserve for the indication of hepatic resection: how I do it
    Gian Massimo Gazzaniga
    Department of Surgery, HPB Unit, Galliera Hospital Genova, Via A. Volta 1, 16100 Genoa, Italy
    J Hepatobiliary Pancreat Surg 12:27-30. 2005
    ..However, a good multifactorial system that combines several elements (clinical, laboratory, functional, and volumetric evaluation) does provide sufficient data for determining the safe limits of hepatectomy...
  23. ncbi Motion - all patients with NASH need to have a liver biopsy: arguments for the motion
    Jayant A Talwalkar
    Mayo Clinic and Foundation, Rochester 55902, USA
    Can J Gastroenterol 16:718-21. 2002
    ..Only histological examination can establish the diagnosis of NASH, grade its severity, determine the prognosis and guide treatment...
  24. ncbi Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass
    Ninh T Nguyen
    Department of Surgery, Medical Center, University of California Davis, Sacramento, CA, USA
    Am J Surg 186:40-4. 2003
    ..Pneumoperitoneum has been shown to reduce hepatic portal blood flow and alter postoperative hepatic transaminases. This study evaluated the changes in hepatic function after laparoscopic and open gastric bypass (GBP)...
  25. ncbi Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii
    Amy C Brown
    Department of Complementary and Alternative Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA
    Clin Toxicol (Phila) 45:549-56. 2007
    To determine the effects of traditionally prepared kava beverages on the liver function tests of regular kava beverage consumers in a population of Tongan and non-Tongan residents of Hawaii (Oahu).
  26. ncbi Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients
    Chien-Wei Su
    Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Gastroenterology 130:1625-35. 2006
    ..CONCLUSIONS: In chronic HBV and HDV dual infections, older age, genotype I HDV, and genotype C HBV correlated with adverse outcomes...
  27. ncbi Liver function tests in metastatic uveal melanoma
    Igor Kaiserman
    Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel
    Am J Ophthalmol 137:236-43. 2004
    To evaluate trends in liver function tests before detection of liver metastases from uveal melanoma.
  28. ncbi Measurement of liver function for patients with cirrhosis by 13C-methacetin breath test compared with Child-Pugh score and routine liver function tests
    Yun-Xiang Liu
    Department of Gastroenterology, Yantai Yuhuangding Hospital, Affiliated to Medical College of Qingdao University, Yantai 264000, China
    Chin Med J (Engl) 119:1563-6. 2006
  29. ncbi Health outcomes following liver function testing in primary care: a retrospective cohort study
    David J McLernon
    Medical Statistics Team, Section of Population Health, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB25 2ZD, UK
    Fam Pract 26:251-9. 2009
    patients who present with abnormal liver function tests (LFTs) in primary care and no obvious symptoms can be difficult to manage.
  30. ncbi Quantitative assessment of hepatic function and its relevance to the liver surgeon
    G Morris-Stiff
    Department of Hepatobiliary and Transplant Surgery, St James s Hospital, Leeds, UK
    J Gastrointest Surg 13:374-85. 2009
    ....
  31. ncbi Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI
    Henrik Nilsson
    Karolinska Institutet, Sweden
    J Magn Reson Imaging 29:1323-31. 2009
    ..To assess the feasibility to use dynamic hepatocyte-specific contrast-enhanced MRI (DHCE-MRI) as an imaging-based liver function test, and to compare two methods for deconvolutional analysis (DA) in healthy human subjects...
  32. ncbi Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy
    Gwo-Tzer Ho
    Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK
    Eur J Gastroenterol Hepatol 16:157-62. 2004
    ..We studied the prevalence and aetiology of abnormal liver function tests following bone marrow transplantation and the role of liver biopsy...
  33. ncbi Occupational lead exposure and amino acid profiles and liver function tests in industrial workers
    F R Al Neamy
    Department of Biochemistry, Al Ain Hospital, Ministry of Health, Al Ain, United Arab Emirates
    Int J Environ Health Res 11:181-8. 2001
    ..These results might be related to lead exposure and might have affects on the kidneys or liver...
  34. ncbi The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002
    George N Ioannou
    Research Enhancement Award Program, Department of Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Am J Gastroenterol 101:76-82. 2006
    ..This prevalence is very high (7.3%) even among persons without viral hepatitis C or excessive alcohol consumption and is strongly associated with risk factors for nonalcoholic fatty liver disease...
  35. ncbi High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo
    Frank Tacke
    Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
    J Hepatol 42:666-73. 2005
    ....
  36. ncbi Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C
    Vincent Leroy
    Département d Hépato Gastroentérologie, CHU de Grenoble, BP 217, 38043 Grenoble Cedex 9, France
    J Hepatol 46:775-82. 2007
    ..The aim of this study was to compare the diagnostic performance of 6 scores (MP3, Fibrotest, Fibrometer, Hepascore, Forns' score and APRI)...
  37. ncbi Review article: breath testing for human liver function assessment
    A Armuzzi
    Department of Internal Medicine, Catholic University, Rome, Italy
    Aliment Pharmacol Ther 16:1977-96. 2002
    ....
  38. ncbi Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
    Sylvie Naveau
    Department of Hepato-Gastroenterology, , Clamart, France
    Clin Gastroenterol Hepatol 3:167-74. 2005
    ..CONCLUSIONS: In heavy drinkers, FT is a simple and noninvasive quantitative estimate of liver fibrosis. The use of FT may decrease the need for liver biopsy examination...
  39. ncbi [Pre- and postoperative transaminase changes within the scope of gastric banding in morbid obesity]
    S Albert
    , Departement Innere Medizin, Kantonsspital St. Gallen
    Praxis (Bern 1994) 90:1459-64. 2001
    ..The normalisation of elevated liver enzymes correlates to the extent of weight reduction after gastric banding. Our data show reversible liver enzyme abnormalities, correlating to the degree of obesity...
  40. ncbi Liver function tests in patients of pulmonary tuberculosis using four different drug regimens
    M Z Akbri
    Department of Biochemistry, Allama Iqbal Medical College, Lahore
    J Ayub Med Coll Abbottabad 13:5-10. 2001
    ..Antituberculous therapy causes derangement of hepatic functions revealed by disturbed liver function tests. The incidence of side effects may vary depending upon a number of factors...
  41. ncbi Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure
    I Gallardo Wong
    Laboratory of Gastrohepatology Research, Hospital de Pediatria, CMN, Siglo XXI, IMSS Av Cuauhtemoc 330, Colonia Doctores, Delegacion Cuauhtemoc, Mexico
    World J Gastroenterol 13:4579-85. 2007
    ..To evaluate the prognostic value of percentage of (13)C-phenylalanine oxidation ((13)C-PheOx) obtained by (13)C-phenylalanine breath test ((13)C-PheBT) on the survival of patients with chronic liver failure...
  42. ncbi Evaluation of abnormal liver function tests
    J K Limdi
    Tameside General Hospital, Ashton under Lyne, Manchester, UK
    Postgrad Med J 79:307-12. 2003
    Interpretation of abnormalities in liver function tests is a common problem faced by clinicians. This has become more common with the introduction of automated routine laboratory testing...
  43. ncbi FibroMAX: towards a new universal biomarker of liver disease?
    Rachel Morra
    Groupe Hospitalier Pitie Salpetriere, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
    Expert Rev Mol Diagn 7:481-90. 2007
    ..The possible causes of false-negative and false-positive results are also better identified. These tests, which are now available in 50 countries, can facilitate the screening and management of the most frequent liver diseases...
  44. ncbi The utility of liver function tests in dengue
    Manzhi Wong
    Ann Acad Med Singapore 37:82-3. 2008
  45. ncbi 13C-breath tests in hepatology (cytosolic liver function)
    F Perri
    Dpt. of Gastroenterology and Digestive Endoscopy Casa Sollievo della Sofferenza, Hospital, IRCCS, San Giovanni Rotondo, Italy
    Eur Rev Med Pharmacol Sci 8:47-9. 2004
    ..Both BTs are not affected by enzymatic induction due to drugs which may interfere with the results of the classic "microsomial" BTs (such as the aminopyrine or caffeine BTs)...
  46. ncbi Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran)
    Fariborz Mansour-Ghanaei
    Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
    Med Sci Monit 8:CR797-800. 2002
    The aim of this study was to determine the seroprevalence of hepatitis B and C viruses and abnormal liver function tests among hemophiliacs in Guilan province, Iran.
  47. ncbi Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders
    Concetta Montagnese
    Human Nutrition, Department of Food Science, Federico II University, Naples, Italy
    Int J Eat Disord 40:746-50. 2007
    ..The present study aimed to evaluate serum liver enzymes in underweight outpatients with anorexia nervosa (A-NERV) or eating disorders not otherwise specified (EDNOS)...
  48. ncbi Abdominal ultrasound in the evaluation of the asymptomatic patient with abnormal liver function tests
    R F J Browne
    Department of Radiology, The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland
    Ir Med J 97:49-50. 2004
    We retrospectively evaluated abdominal ultrasound studies of 273 asymptomatic patients with abnormal liver function tests over an 18-month period to assess the value of abdominal ultrasound as an initial investigation...
  49. ncbi Liver function tests: defining what's normal
    Paul Roderick
    Community Clinical Sciences Research Division, University of Southampton, B Floor, South Academic Block, Southampton General Hospital, Southampton SO16 6YD
    BMJ 328:987. 2004
  50. ncbi Quantitative liver function tests in donors and recipients of living donor liver transplantation
    Christoph Jochum
    Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg Essen, Essen, Germany
    Liver Transpl 12:544-9. 2006
    ..In the present study we investigated the quantitative liver function tests galactose elimination capacity (GEC), indocyanine green half-life (ICG), and lidocaine half-life as markers ..
  51. ncbi Association of ADIPOR2 with liver function tests in type 2 diabetic subjects
    Abel Lopez-Bermejo
    Diabetes, Endocrinology and Nutrition Unit, Dr Josep Trueta Hospital, Girona, Spain
    Obesity (Silver Spring) 16:2308-13. 2008
    ..We studied whether common single-nucleotide polymorphisms (SNPs) in ADIPOR1 and ADIPOR2 are associated with liver function tests (LFTs) in human subjects with various degrees of insulin resistance.
  52. ncbi Quantitative rat liver function test by galactose single point method
    T H Young
    Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
    Lab Anim 42:495-504. 2008
    ..The GSP method has been proved to be a simple and useful tool for the quantitative determination of liver function in rats, which can possibly be extended to other animals...
  53. ncbi Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis
    Frank Tacke
    Hepatology 48:1724-5; author reply 1725-6. 2008
  54. ncbi Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients
    Alexander Koch
    Department of Medicine III, RWTH University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany
    Crit Care 13:R95. 2009
    ..We aimed to examine the correlation of serum resistin concentrations to parameters of inflammation, organ function, metabolism, disease severity and survival in critically ill patients...
  55. ncbi Design and endpoints of clinical trials in hepatocellular carcinoma
    Josep M Llovet
    HCC Translational Research Lab, Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clinic, CIBERehd, Institute for Biomedical Investigations August Pi Sunyer, Villarroel 170, 08036 Barcelona, Catalonia, Spain
    J Natl Cancer Inst 100:698-711. 2008
    ..These surrogate markers may help to enrich study populations and maximize the cost-benefit ratio of trial execution. Design and conduct of phase 3 trials should be coordinated by centers with appropriate expertise in HCC...
  56. ncbi [13C] phenylalanine breath test and hepatic phenylalanine metabolism enzymes in cirrhotic rats
    W Yan
    Department of Gastroenterology, Huashan Hospital Affiliated to Fudan University, Shanghai, PR China
    Eur J Clin Invest 35:644-52. 2005
    ....
  57. ncbi Current therapy for autoimmune hepatitis
    Aldo J Montano Loza
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Nat Clin Pract Gastroenterol Hepatol 4:202-14. 2007
    ....
  58. ncbi Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study
    Luigi Addario
    , Azienda Ospedaliera A. Cardarelli, Napoli, Italy
    Eur J Gastroenterol Hepatol 18:713-20. 2006
    BACKGROUND AND AIMS: Widespread application of quantitative liver function tests as a prognostic tool is controversial...
  59. ncbi Seasonal variation in liver function tests: a time-series analysis of outpatient data
    Kazunori Miyake
    Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Hongo 2 1 1, Bunkyo ku, Tokyo 113 8421, Japan
    Ann Clin Biochem 46:377-84. 2009
    Long-term physiological variations, such as seasonal variations, affect the screening efficiency at medical checkups. This study examined the seasonal variation in liver function tests using recently described data-mining methods.
  60. ncbi Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis
    N Koeda
    First Department of Internal Medicine, Iwate Medical University, School of Medicine, 19-1 Uchimaru, Morioka 020-8505, Iwate, Japan
    Aliment Pharmacol Ther 21:851-9. 2005
    ....
  61. ncbi Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease
    M C Devers
    Department of Diabetes, Glasgow Royal Infirmary, Glasgow, UK
    Diabet Med 25:523-9. 2008
    The definition of metabolic syndrome (MS) continues to be debated and does not include abnormal liver function tests (LFTs)...
  62. ncbi Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy
    Ferdinand W N M Wit
    National AIDS Therapy Evaluation Center, Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands
    J Infect Dis 186:23-31. 2002
    ..In 97% of cases, >or=1 risk factor was present. In HBV-coinfected patients using 3TC, continued use of 3TC should be considered, even if 3TC-resistant HIV strains develop...
  63. ncbi A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans
    Richard K Sterling
    Division of Gastroenterology, Virginia Commonwealth University Medical Center, Richmond 23298 0341, USA
    Clin Gastroenterol Hepatol 2:469-73. 2004
    ..Differences in hepatitis C virus (HCV)-related liver disease between Caucasians and African Americans remain controversial...
  64. ncbi Silent acetaminophen-induced hepatotoxicity in febrile children: does this entity exist?
    R Shaoul
    Department of Paediatrics, Bnai Zion Medical Centre, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Acta Paediatr 93:618-22. 2004
    ..Our hypothesis is that in sick febrile infants and children, who may also be calorie depleted, there might be an increased hepatic vulnerability to acetaminophen...
  65. ncbi Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis
    Hui juan Cui
    Chinese Japanese Friendship Hospital, Beijing 100029, China
    World J Gastroenterol 10:1652-5. 2004
    ..To evaluate the hepatic function in patients with severe acute respiratory syndrome (SARS) and possible causes of hepatic disorder in these patients...
  66. ncbi An assessment of statin safety by hepatologists
    David E Cohen
    Division of Gastroenterology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Cardiol 97:77C-81C. 2006
    ..The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity...
  67. ncbi Parameters obtained by hepatobiliary scintigraphy have significant correlation with biochemical factors early after liver transplantation
    H A Kansoul
    Division of Transplantation Surgery, Department of Clinical Science, Intervention, and Technology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    Acta Radiol 48:597-604. 2007
    ..Early postoperative hepatobiliary scintigraphy after liver transplantation is performed worldwide, but data on its significance for graft function are currently limited...
  68. ncbi RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity
    A Walubo
    The Department of Pharmacology, University of the Free State, Bloemfontein, South Africa
    Methods Find Exp Clin Pharmacol 28:423-31. 2006
    ..This suggested that nevirapine-induced hepatotoxicity is closely associated with enzyme induction, and that liver function tests alone might not be good markers for determining nevirapine-induced hepatotoxicity...
  69. ncbi Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease
    Jane L Hartley
    Birmingham Children s Hospital, UK
    J Pediatr Gastroenterol Nutr 43:217-21. 2006
    ..Hyaluronic acid (HA) is removed by the liver via sinusoidal cell adhesion molecules. This is impeded in fibrosis, leading to a rise in serum HA. As a noninvasive marker of fibrosis, HA may obviate the need for liver biopsy...
  70. ncbi Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients
    Madiha Mahmoud
    Pharmacology Department, Theodor Bilharz Research Institute, Egypt
    Eur J Pharmacol 569:222-7. 2007
    ..Blood samples were collected from all subjects for examination, using conventional liver function tests. The pharmacokinetic variables for antipyrine were determined using the two concentration time points ..
  71. ncbi External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis
    Angelo Iacobellis
    Division of Gastroenterology, Hospital Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo, Italy
    Am J Gastroenterol 100:868-73. 2005
  72. ncbi Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial
    Raimondo Ascione
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom
    Ann Thorac Surg 81:97-103. 2006
    ..We investigated the efficacy of coronary surgery with or without cardiopulmonary bypass in protecting the function of the small intestine, liver, and pancreas...
  73. ncbi Clinical significance of arginase after liver transplantation
    Fathi Ashamiss
    Department of General and Transplantation Surgery, Transplantation Institute, Medical University of Warsaw, Poland
    Ann Transplant 9:58-60. 2004
    ..The values showed strong and significant correlation with AST and ALT activities (Pearsons R 0,65 and 0,47 respectively). We conclude that activity of arginase in the serum is an exact test of liver function...
  74. ncbi Strategies for safer liver surgery and partial liver transplantation
    Pierre-Alain Clavien
    Swiss Hepato-Pancreatico-Biliary (HPB) Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland
    N Engl J Med 356:1545-59. 2007
  75. ncbi The influence of small doses of paracetamol on rabbit liver
    Izabela Maciejewska Paszek
    Department of Food and Nutrition, Medical University of Silesia, 41 200 Sosnowiec, Jagiellońska 4 Street, Katowice, Poland
    Exp Toxicol Pathol 59:139-41. 2007
    ..It was determined by measuring the concentration of ketone bodies and arterial ketone body ratio (AKBR) value. Even when taken in small doses, paracetamol causes changes in liver metabolism when taken for an extended period of time...
  76. ncbi Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort
    Carlo Torti
    Istituto di Malattie Infettive e Tropicali, Universita degli Studi di Brescia, p le Spedali Civili 1, Brescia, Italy
    BMC Infect Dis 5:58. 2005
    ....
  77. ncbi Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue
    Masato Yoneda
    Division of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    Alcohol Clin Exp Res 31:S15-21. 2007
    ..Recent evidence has indicated that hypoadiponectinemia is involved in hepatic steatosis and NASH...
  78. ncbi Aqueous garlic extract alleviates ischaemia-reperfusion-induced oxidative hepatic injury in rats
    Goksel Sener
    Department of Pharmacology, Marmara University School of Pharmacy, Tibbiye Cad 34668 Istanbul, Turkey
    J Pharm Pharmacol 57:145-50. 2005
    ....
  79. ncbi Interleukin-10 mediates the protective effect of Linomide by reducing CXC chemokine production in endotoxin-induced liver injury
    Xiang Li
    Department of Surgery, , Lund University, Sweden
    Br J Pharmacol 143:865-71. 2004
    ....
  80. ncbi Increased liver chemistry in an asymptomatic patient
    Wolfram Goessling
    Harvard Medical School, Boston, Massachusetts; Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
    Clin Gastroenterol Hepatol 3:852-8. 2005
  81. ncbi Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury
    Joseph George
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032, USA
    Clin Chim Acta 348:189-97. 2004
    ..However, levels are increased only transiently, indicating that serial assays are necessary. CONCLUSIONS: Measures of circulating hyaluronidase activity may be used to assess liver damage...
  82. ncbi HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease
    David Nunes
    Section of Gastroenterology, Boston Medical Center, Boston University, Boston, MA 02118, USA
    J Acquir Immune Defic Syndr 40:538-44. 2005
    ..The aim of the current study was to compare the diagnostic performance and characteristics of a number of noninvasive markers of hepatic fibrosis in populations of hepatitis C virus (HCV)-infected patients with and without HIV infection...
  83. ncbi Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction
    Leo C C Kum
    Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, China
    Clin Cardiol 29:295-9. 2006
    ..312). CONCLUSION: The prevalence of SLD in Chinese patients taking oral amiodarone with or without elevated baseline ALT was similar (4.4 vs. 3.7%). It seems that amiodarone may be safely prescribed in patients with elevated baseline ALT...
  84. ncbi [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]
    Ping Liu
    Research Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    Zhong Xi Yi Jie He Xue Bao 1:89-98, 102. 2003
    ..Fuzheng Huayu Capsule is a safe and effective medicine for the treatment of liver fibrosis in chronic hepatitis B...
  85. ncbi Antioxidative natural product protect against econazole-induced liver injuries
    Chi-Feng Liu
    National Taipei College of Nursing, Taipei 112, Taiwan
    Toxicology 196:87-93. 2004
    ..It could be postulated that the hepatoprotective effect of PEE may be, at least in part, due to their inhibitory ability on membrane lipid peroxidation and free radical formation or due to their free radical scavenging ability...
  86. ncbi Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation
    Erika Martinez-Lopez
    Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, and Health Sciences University Center CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico
    Liver Int 27:930-7. 2007
    ..The clinical implication of such changes is unclear, but these could reflect recovery and/or severity of liver damage...
  87. ncbi Hepatoprotective effect of Leucophyllum frutescens on Wistar albino rats intoxicated with carbon tetrachloride
    Isaias Balderas-Renteria
    Laboratory of Genetic Engineering and Genomics, Facultad de Ciencias Quimicas, Universidad Autonoma de Nuevo Leon, Mexico
    Ann Hepatol 6:251-4. 2007
    ..The present study scientifically validated the traditional use of L. frutescens for liver disorders. In conclusion the methanol extract of L. frutescens aerial parts could be an important source of hepatoprotective compounds...
  88. ncbi Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Ramsey C Cheung
    VA Palo Alto Healthcare System, Palo Alto, CA 94304, USA
    J Clin Gastroenterol 42:827-34. 2008
    ..To determine the validity of fibrosis indexes based on simple laboratory tests in daily practice...
  89. ncbi Ultrustructural and enzymatic studies of rat liver after acute cadmium exposure
    Elzbieta Czykier
    Departments of Histology and Embryology, Clinical Pathomorphology, , , Poland
    Rocz Akad Med Bialymst 47:203-12. 2002
    ..However, a single 5 mumol CdCl2/kg b.w. dose induced only blurring of cell structure in single hepatocytes within the peripheral zone of the lobules, which looked as if they had been filled with pinkish "mush"...
  90. ncbi Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings
    Päivi Halonen
    Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland
    Med Pediatr Oncol 40:148-54. 2003
    ..During modern intensified therapy for childhood acute lymphoblastic leukemia (ALL) serum liver enzymes reach fairly high levels. Since no recent data on liver histopathology after therapy are available, we conducted a study of the subject...
  91. ncbi Restoration of histoarchitecture in the paracetamol-induced liver damaged rat by earthworm extract, Lampito mauritii (Kinberg)
    M Balamurugan
    Division of Vermibiotechnology, Department of Zoology, Annamalai University, Annamalai Nagar, India
    Eur Rev Med Pharmacol Sci 11:407-11. 2007
    ..05) decreasing the hepatic marker enzymes--aspartate transaminase, alanine transaminase and alkaline phosphatase similar to silymarin (150 mg/kg b.w. p.o.). Histopathological observations of liver tissues corroborated these findings...
  92. ncbi How to respond to abnormal liver function tests
    Jane Collier
    John Radcliffe Hospital, Oxford
    Clin Med 2:406-9. 2002
  93. ncbi Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats
    Feng Lin Yen
    Graduate Institute of Pharmaceutical Sciences, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
    Food Chem Toxicol 46:1771-7. 2008
    ..In conclusion, we suggest that the nanoparticles system can be applied to overcome other water poorly soluble herbal medicines and furthermore to decrease the treatment dosage...
  94. ncbi [Acetaminophen use by chronic alcohol abusers: a therapeutic dose may be too much for the liver]
    A H van Mil
    Rijnland Ziekenhuis, afd. Interne Geneeskunde en Maag-Darm-Leverziekten, Postbus 4220, 2350 CC Leiderdorp
    Ned Tijdschr Geneeskd 145:1873-6. 2001
    ..It is recommended that chronic alcohol abusers (more than four alcoholic beverages per day) use no more than 2 g acetaminophen per day...
  95. ncbi Extended experience with glycine for prevention of reperfusion injury after human liver transplantation
    P Schemmer
    Department of Surgery and the Childrens Hospital, Division of Metabolic and Endocrine Disease, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany
    Transplant Proc 34:2307-9. 2002
  96. ncbi Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study
    Andrew L Avins
    Kaiser Permanente Division of Research, Oakland, CA 94612, USA
    Drug Saf 31:325-34. 2008
    ..Little is known about the potential adverse hepatic effects of HMG-CoA reductase inhibitors ('statins') in patients with existing liver disease; therefore, we examined the risk of liver toxicity with lovastatin exposure in these patients...
  97. ncbi Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level
    S Fakurazi
    Pharmacology Unit, Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
    Food Chem Toxicol 46:2611-5. 2008
    ..The histological hepatocellular deterioration was also evidenced. The results from the present study suggested that the leaves of MO can prevent hepatic injuries from APAP induced through preventing the decline of glutathione level...
  98. ncbi Intermittent total pedicular clamping in hepatic resections in non-cirrhotic patients
    Rafael Omar Giovanardi
    Department of General Surgery, Universidade de Caxias do Sul and General Hospital, Caxias do Sul, Brazil
    Hepatogastroenterology 49:764-9. 2002
    ..Evaluation of intermittent total pedicular clamping in hepatic resections in non-cirrhotic patients...
  99. ncbi Side effects of statins: hepatitis versus "transaminitis"-myositis versus "CPKitis"
    Carlos A Dujovne
    Am J Cardiol 89:1411-3. 2002
  100. ncbi Toxic liver injury of transplanted liver: a case report of a 15-year-old boy
    J Pawlowska
    Department of Gastroenterology, Hepatology and Nutrition, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-736 Warsaw, Poland
    Transplant Proc 34:628. 2002
  101. ncbi A bright liver
    Maarouf A Hoteit
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 6:xxii. 2008

Research Grants78

  1. Effects of Simvastatin on CSF AD biomarkers in cognitively normal subjects
    Gail Li; Fiscal Year: 2010
    ..Adverse effects (including serum lipids, liver function tests, and creatine phosphokinase levels) will be monitored at 6-weeks and at 3-, 6-, and 12-months...
  2. SELECTIVE PLASMA EXCHANGE THERAPY
    Jacek Rozga; Fiscal Year: 2003
    ..Survival time and changes in intracranial pressure, cerebral perfusion pressure, and standard liver function tests will be examined...
  3. Abcb11 and Hepatic Transport
    Anne Henkel; Fiscal Year: 2007
    ..NAFLD), which is associated with the metabolic syndrome, now represents the most common cause of abnormal liver function tests. "Thrifty genes" are genes that may have conferred a survival advantage to humans thousands of years ago, ..
  4. Early Antipseudomonal Therapy in Cystic Fibrosis
    Bonnie Ramsey; Fiscal Year: 2007
    ..reference to musculo-skeletal symptoms, renal function as measured by serum creatinine, hearing acuity, liver function tests, and complete blood count); clinical variables (occurrence of hospitalization during 18 months, proportion ..
  5. Retrovirus Isolation from Primary Biliary Cirrhosis
    Andrew Mason; Fiscal Year: 2004
    ..In a pilot study of anti-retroviral therapy with Combivir, 40% of patients completely normalized their liver function tests and there was a significant reversal of ductopenia on liver biopsy...
  6. Nonalcoholic fatty liver disease in Hispanic obese youth
    Nancy Butte; Fiscal Year: 2005
    ..Design: Obese Hispanic children and their nonobese siblings will be screened for NAFLD using serum liver function tests; total sample size will be 1000...
  7. EARLY NATURAL HISTORY OF HCV INFECTION AMONG IDUS
    Ronald Hershow; Fiscal Year: 2006
    ..During the course of the study, all patients will be referred to care at the University of Illinois Medical Center Digestive Disease and Liver Center. Biopsies conducted during normal care will also be used for analysis. ..
  8. Alcohol Associated Outcomes Among HIV+/-Aging Veterans
    Amy Justice; Fiscal Year: 2002
    ..Follow Back will be self completed by all patients and validated by interview in a subset, and additional liver function tests will be analyzed on banked specimens (CDT, GGT, ALT, and AST)...
  9. Tumor Neovasculature Vector Targeting
    Albert Deisseroth; Fiscal Year: 2003
    ..will be monitored by a panel of tests during and after treatment, including several types of blood and liver function tests. Efficacy will be monitored by measurements of injected skin tumors, and also of skin tumors and internal ..
  10. Epidemiology of HCV Infection among Egyptian Children
    Gamal Esmat; Fiscal Year: 2006
    ..assess liver function and morbidity in HCV infected children and their controls with clinical examinations, liver function tests, and abdominal ultrasound...
  11. Murine models of non-alcoholic steatohepatitis
    Alexander Igolnikov; Fiscal Year: 2005
    Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver function tests in the United States...
  12. BEH PHARM TREATMENTS FOR ALCOHOL/NICOTINE DEPENDENCE
    Joy Schmitz; Fiscal Year: 2001
    ..Alcohol consumption will be measured by self-report, breath alcohol readings, collateral reports, and liver function tests. Primary efficacy parameters for drinking and smoking will include time to lapse/relapse and cumulative ..